Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: a possible pathogenic role.
Anticardiolipin (aCL) antibodies have been associated with thrombocytopenia, hemolytic anemia and an increased risk of thrombosis in different vascular locations, even in the absence of lupus. The classic hemolytic-uremic syndrome is a postinfectious acute renal failure characterized by hemolytic anemia, thrombocytopenia and the presence of widespread glomerular thrombosis in the kidney, with pathogenic mechanisms that remain to be identified. In order to establish the frequency of aCL antibodies in this syndrome and to identify a possible role in the pathogenesis and clinical manifestations, 17 patients were studied during the reactant phase of the disease looking for an association between the presence of aCL antibodies (isotypes IgG, IgA and IgM) and the main clinical variables of the syndrome. In 8 patients IgG aCL was present, 2 patients had IgM aCL, and 1 had IgA antibodies on the solid-phase ELISA aCL assays, but no association could be demonstrated with the clinical variables studied. Although it might correspond to an epiphenomenon related to the triggering intestinal infection, a pathogenic role cannot be discarded and additional studies should be performed.
Ardiles
L G
LG
Division of Nephrology, Faculty of Medicine, Universidad Austral de Chile, Valdivia.
Olavarría
F
F
Elgueta
M
M
Moya
P
P
Mezzano
S
S
D017153:Antibodies, Anticardiolipin / Q000097:blood*; D002675:Child, Preschool; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000097:blood* / Q000209:etiology; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000097:blood; D007223:Infant; D008297:Male
D017153:Antibodies, Anticardiolipin; D007132:Immunoglobulin Isotypes